Free Trial
→ Millionaire warns: Move your money before May 15 (From Brownstone Research) (Ad)tc pixel Free MBRX Stock Alerts

Moleculin Biotech (MBRX) Institutional Ownership

Moleculin Biotech logo
$2.20 +0.06 (+2.80%)
Closing price 04:00 PM Eastern
Extended Trading
$2.21 +0.01 (+0.50%)
As of 05:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Moleculin Biotech (NASDAQ:MBRX)

Current
Institutional Ownership
Percentage
15.52%
Number of
Institutional Buyers
(last 12 months)
2
Total
Institutional Inflows
(last 12 months)
$22.69M
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$639.07K
Get MBRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Moleculin Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

MBRX Institutional Buying and Selling by Quarter

Moleculin Biotech Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/12/2026 Jane Street Group LLC22,550$75K0.0%N/A1.105%
2/9/2026Geode Capital Management LLC15,138$50K0.0%-92.7%0.742%
5/15/2025Armistice Capital LLC1,250,000$1.22M0.0%+293.6%8.929%
8/15/2024Armistice Capital LLC156,000$549K0.0%+5.1%6.747%
2/13/2024Armistice Capital LLC3,207,417$2.75M0.0%N/A9.600%
1/17/2024Atticus Wealth Management LLC50,001$43K0.0%N/A0.168%
5/15/2023Sio Capital Management LLC1,010,956$971K0.5%-2.5%3.407%
7/25/2022Walker Asset Management LLC20,708$32K0.0%N/A0.072%
4/20/2022Sigma Planning Corp57,500$102K0.0%+33.7%0.201%


MBRX Institutional Ownership - Frequently Asked Questions

During the previous two years, the following institutional investors and hedge funds held shares of Moleculin Biotech shares: Armistice Capital LLC ($1.22M), and Jane Street Group LLC ($75K), Geode Capital Management LLC ($50K).Learn more on Moleculin Biotech's institutional investors.

15.52% of Moleculin Biotech's stock is owned by institutional investors. Learn more on MBRX's institutional investor holdings.

The following institutional investors have purchased Moleculin Biotech's stock in the last 24 months: Armistice Capital LLC ($939.92K), and Jane Street Group LLC ($22.55K).

Institutional investors have bought a total of 954,964 shares in the last 24 months. This purchase volume represents approximately $22.69M in transactions.

The following institutional investors have sold Moleculin Biotech stock in the last 24 months: Geode Capital Management LLC ($193.07K).

Institutional investors have sold a total of 193,072 shares in the last 24 months. This volume of shares sold represents approximately $639.07K in transactions.


Related Companies

This page (NASDAQ:MBRX) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners
Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...
Weiss Ratings | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Trump is positioned. Elon lights the fuse.
Bitcoin is back above $80,000. Altcoins are pumping. ETF inflows are accelerating. The CLARITY Act… the most b...
Crypto 101 Media | Sponsoredtc pixel
Peptide Company Lands Exclusive MMA Wellness Partnership
A publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform t...
The Tomorrow Investor | Sponsoredtc pixel
I’m sounding the alarm
Meta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...
Porter & Company | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel